Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6

Affiliations

¹ Institute of Pathology, Medical University of Graz, Graz, Austria.
² Center for Biomarker Research in Medicine, Graz, Austria.
³ Institute of Molecular Biosciences, Karl-Franzens-University of Graz, Graz, Austria.
⁴ Department of Surgery, Hospital Brothers of Charity Graz, Graz, Austria.
⁵ Institute of Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
⁶ Institute of Cell Biology, Histology and Embryology, Medical University Graz, Graz, Austria.
⁷ Department of Surgery, Medical University of Graz, Graz, Austria.
⁸ Experimental Pharmacology & Oncology Berlin GmbH-Berlin-Buch, Berlin, Germany.
⁹ Bayer AG, Berlin, Germany.
¹⁰ Max Planck Institute for Molecular Genetics, Berlin, Germany.
¹¹ Eli Lilly & Company, Indianapolis, USA.
¹² Cpo - cellular phenomics & oncology Berlin-Buch GmbH, Berlin, Germany.
¹³ Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
¹⁴ Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
¹⁵ Department of Pathology, Hospital Graz South-West, Austria.
¹⁶ Department of Pathology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

Published Erratum

Nicole Golob-Schwarzl et al. Oncotarget. 2023.

. 2023 Feb 2:14:83-84.

doi: 10.18632/oncotarget.28115.

¹ Institute of Pathology, Medical University of Graz, Graz, Austria.
² Center for Biomarker Research in Medicine, Graz, Austria.
³ Institute of Molecular Biosciences, Karl-Franzens-University of Graz, Graz, Austria.
⁴ Department of Surgery, Hospital Brothers of Charity Graz, Graz, Austria.
⁵ Institute of Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
⁶ Institute of Cell Biology, Histology and Embryology, Medical University Graz, Graz, Austria.
⁷ Department of Surgery, Medical University of Graz, Graz, Austria.
⁸ Experimental Pharmacology & Oncology Berlin GmbH-Berlin-Buch, Berlin, Germany.
⁹ Bayer AG, Berlin, Germany.
¹⁰ Max Planck Institute for Molecular Genetics, Berlin, Germany.
¹¹ Eli Lilly & Company, Indianapolis, USA.
¹² Cpo - cellular phenomics & oncology Berlin-Buch GmbH, Berlin, Germany.
¹³ Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
¹⁴ Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
¹⁵ Department of Pathology, Hospital Graz South-West, Austria.
¹⁶ Department of Pathology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.